MKP-1 knockout does not prevent glucocorticoid-induced bone disease in mice.
Glucocorticoid-induced osteoporosis (GCOP) is predominantly caused by inhibition of bone formation, resulting from a decrease in osteoblast numbers. Employing mouse (MBA-15.4) and human (MG-63) osteoblast cell lines, we previously found that the glucocorticoid (GC) dexamethasone (Dex) inhibits cellu...
Main Authors: | Conradie, M, Cato, A, Ferris, W, De Wet, H, Horsch, K, Hough, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Glucocorticoids inhibit osteoblast proliferation via transcriptional upregulation of MKP-1: A prime target for the development of novel osteo-anabolic agents
by: Hulley, P, et al.
Published: (2003) -
Rapid inhibitory effects of glucocorticoids on ERK activity and osteoblast proliferation occur via transcriptional upregulation of MKP-1
by: Horsch, K, et al.
Published: (2004) -
Rapid inhibitory effects of glucocorticoids on ERK activity and osteoblast proliferation occur via transcriptional upregulation of MKP-1
by: Horsch, K, et al.
Published: (2004) -
Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo.
by: Conradie, M, et al.
Published: (2007) -
Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate.
by: Hulley, P, et al.
Published: (2002)